Диссертация (1140217), страница 24
Текст из файла (страница 24)
- №8. – Р. 1674-1680.14380.Hall A.P., Ashton S., Horner J., Wilson Z., Reens J., Richmond G.H., BarryS.T., Wedge S.R. PDGFR inhibition results in pericyte depletion andhaemorrhage into the corpus luteumof the rat ovary // Toxicologic Pathlogy. 2016. - Jan. - Vol.44. - №1. - Р. 98-111.81.Iijima K., Jiang J.Y., Shimizu T., Sasada H., Sato E. Acceleration of folliculardevelopment by administration of vascular endothelial growth factor incycling female rats // Journal of Reproduction and Development.
- 2005. №51. - Р. 161-168.82.Jelkmann W. Pitfalls in the Measurement of Circulating Vascular EndothelialGrowth Factor // Clincal Chemistry. -2001. - Vol.47. - №4. - Р. 617-623.83. Kaczmarek M.M., Schams D., Ziecik A. J. Role of vascular endothelialgrowth factor in ovarian physiology – an overview // Reproductive Biology.
2005. - Vol.5. - №2. - Р. 111-131.84.Kamat B.R., Brown L.F., Manseau E.J., Senger D.R., Dvorak H.F. Expressionof Vascular Permeability Factor/Vascular Endothelial Growth Factor byHuman Granulosa and Theca Lutein Cells. Role in Corpus LuteumDevelopment // American Journal of Pathology. - 1995. - Jan.
- Vol.14. - №1.- Р. 157-165.85.Kendall R.L., Thomas K.A. Inhibition of vascular cell growth factor activityby an endogenously encoded soluble endothelial receptor // Proc Natl AcadSci USA. - 1993. - №90 .- Р. 10705 – 10709.86.Kizuka F., Tocuda N., Takagi K., Adachi Y., Lee L., Tamura I., Maekawa R.,Taketani T., Tamura H., Suzuki T., Owada Y., Sugino N. Involvement ofbone marrow-derived vascular progenitor cells in neovascularization duringformation of corpus luteum in mice // Biology of Reproduction. - 2012. Vol.87.
- №3. - Р. 55.87.Luttin A., Tjwa M., Carmeleit P. Placental growth factor (PIGF) and itsreceptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders// Ann. NY Acad. Sci. – 2002. - Vol.979. - Р. 80-93.14488.Lower A.M., Hawthorn R.J.S., Ellis H., O’Brien F., Buchan S., Crowe A.M.The impact of adhesions on hospital readmissions over ten years after 8849open gynaecological operations: an assessment from Surgical and ClinicalAdhesions Research Study // British journal of Obstetrics and Gynaecology. 2000. - July.- №107. - Р. 855-862.89.Martinelli Christensen A.
C. Effect of progesterone priming on ovarianangiogenic factors during late follicular and early luteal development //Institute of Biological, Environmental and Rural Sciences. AberystwythUniversity., 2009. - p. 208.90.Mascarenhas M.N., Flaxman S. R., Boerma T., Vanderpoe S., Stevens G.A.National, regional, and global trends in infertility prevalence since 1990: asystematic analysis of 277 health surveys.[электронный ресурс] // PLOSMedicine.-12 December 2012.-Vol.
9 - p.1-12. - Режим доступа:http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001351.91.Mllhenny C., George W.D., Doughty J.C. A comparison of serum and plasmalevels of vascular endothelial growth factor during the menstrual cycle inhealthy female volunteers // British Journal of Cancer. - 2002. - №86. - Р.1786-1789.92.Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z.
Vascular endothelialgrowth factor (VEGF) and its receptors // The FASEB Journal. - 1999. - Jan. №13. - Р. 9-22.93.Otani N., Minami S., Yamoto M., Shikone T., Otani H., Nishiyama R., OtaniT., Nakano R. The Vascular Endothelial Growth Factor/fms-LikeTyrosineKinase System in Human Ovary during the Menstrual Cycle and EarlyPregnancy // The Journal of Clinical Endocrinology and Metabolism. - 1999. Vol.84.
- №10. - Р. 3845–3851.94.Parborell F., Irusta G., Rodrigez Celin A., Tesone M. Regulation of ovarianangiogenesis and apoptosis by GnRH-I analogs // Molecular Reproduction andDevelopment. - 2008. - Apr. - Vol.75. - №4. - Р. 623-631.14595.Polec A., Raki M., Abyholm T.,Tanbo T.G., Fedorcsak P.
Interaction betweengranulosa-lutein cells and monocytes regulates secretion of angiogenic factorsin vitro // Human Reproduction. - 2011. - Oct. - Vol.26. - №10. - P. 28192829.96.Reynolds L.P., Killilea S.D., Redmer. D.A. Angiogenesis in femalereproductive system // The FASEB journal.
- 1992. - Feb. - №6. - Р. 886-892.97.Robinson R.S., Woad K.J., Hammond A.J., Laird M., Hunter M.G., MannG.E. Angiogenesis and vascular function in the ovary // Soсiety forReproduction and Fertility. - 2009. - №138. - Р. 869-881.98.Seehusen D.A., Earwood S. Oral contraceptives are not an effective treatmentfor ovarian cysts // American Family Physician. - 2014. - Nov. - Vol.1 №90(9). - Р. 623.99.Sleer L.S., Taylor C.C. Platelet-derived growth factors and receptors in the ratcorpus luteum: localization and identification of an effect on luteogenesis //Biology of Reproduction. -2007.
- Vol.76. - №3. - P. 391-400.100. Stouffer R.L., Bishop C.V., Bogan R.L., Xu F., Hennebold J.D. Endocrineand local control of the primate corpus luteum // Biology of Reproduction. 2013. - Vol.13 - №4. - P. 259-271.101. Sugino N., Kashida S., Takiguchi S., Karube A., Kato H. Expression ofVascular Endothelial Growth Factor and Its Receptors in the Human CorpusLuteum during the Menstrual Cycle and in Early Pregnancy // The Journal ofClinical Endocrinology and Metabolism. - 2000.
– Oct.1. - Vol.85. - №10. - Р.3919-3924.102. Taylor P.D., Wilson H., Hillier S.G., Wiegand S.J., Fraser H.M. Effects ofinhibition of vascular endothelial growth factor at time of selection onfollicular angiogenesis, expansion, development and atresia in the marmoset //Molecular Human Reproduction. - 2007. - Oct. - Vol.13. - №10. - Р.
729-736.103. Tomac J., Cekinovic D., Arapovic J. Biology of the Corpus luteum //Periodicum Biologorum. - 2011. - Vol.113. - №1. - Р. 43–49.146104. Trau H.A., Davis J.S., Duffy D.M. Angiogenesis in primate ovulatoryfollicle is stimulated by luteinizing hormone via prostaglandin E2 // Biologyof Reproduction. - 2015. - Jan. - Vol.92. - №1. - P.15.105.
Tropea A., Lanzone A., Tiberi F., Romani F., Catino S., Apa R. Estrogensand androgens affect human luteal cell function // Fertility and Sterility. -2010.- Nov. - Vol.96. - №6. - Р. 2257-2263.106. Tropea A., Miceli F., Micini F., Tiberi F., Orlando M., Romani F., Catino S.,Mancuso S., Navarra P., Lanzone A., Apa R. Regulation ofvascularendothelial growth factor synthesis and release by human luteal cells in vitro //The Journal of Clinical Endocrinology and Metabolism. - 2006. - Jun. Vol.91. - №6. - Р. 2303-2309.107. Zimmermann R.C., Hartman T., Kavic S., Pauli S.A., Bohlen P., Sauer M.V., Kitajewski J.
Vascular endothelial growth factor receptor 2–mediatedangiogenesis is essential for gonadotropin-dependent follicle development //Journal Clinical Investigation. - 2003. – Sept. 1.- Vol.112. - №5. - Р. 659–669.108. Zimmermann R.C., Xiao E., Bolhen P., Ferin M. Administration ofAntivascular Endothelial Growth Factor Receptor 2 Antibody in the EarlyFollicular Phase Delays Follicular Selection and Development in the RhesusMonkey // Endocrinology by The Endocrine Society. - 2002.
- Vol.143. - №7.- Р. 2496–2502..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
